STK11 and cancer: Currently, most scholars believe that metformin can reduce the risk of PC, because metformin can activate the liver kinase B1 (LKB1)–adenosine monophosphate protein-activated kinase (AMPK) pathway, which can not only promote cell energy production and inhibit liver glucose production but also inhibit the signal pathway of cancer cell proliferation (103).